36
Participants
Start Date
July 31, 2014
Primary Completion Date
January 31, 2018
Study Completion Date
May 31, 2018
Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™)
Application of up to 18 mL of autologous PRP gel (Magellan® Bio-Bandage™) to the surface of an acute deep partial thickness burn wound no greater than 72 cm squared within 72 hours of the initial injury. Intervention is in addition to standard of care treatment. The PRP Bio-Bandage™ is prepared using the Magellan® System and is FDA cleared via BK030040 and BK040068.
Lehigh Valley Health Network, Allentown
MedStar Health Research Institute, Washington D.C.
Jaycee Burn Center at University of North Carolina, Chapel Hill
Tampa General Hospital/University of South Florida, Tampa
Firefighters' Regional Burn Center, Memphis
Arizona Burn Center, Phoenix
University Medical Center Southern Nevada, Lions Regional Burn Center, Las Vegas
University of California, Davis Medica Center, Sacramento
Lead Sponsor
Department of Health and Human Services
FED
Arteriocyte, Inc.
INDUSTRY